Faron Pharmaceuticals Oy Share Discussion Threads

[davidlloyd] 05/5/2020 08:59

Surprisingly muted reaction to the positive news today.....is this just staying under the radar and being missed?
DL

[timberwolf3] 05/5/2020 07:43

RNS out - good news on Clevegen;

[timberwolf3] 04/5/2020 17:07

Well Markku Jalkanen seems convinced that Traumakine can help treat symptoms of covid19 and for WHO to include it in the solidarity trials suggest it is with merit for fasttrack investigation. Agree about Clevegen .

[toffeeman] 04/5/2020 16:39

I am not convinced about Traumakine, Clevegen is likely to be the game changer here.

[timberwolf3] 04/5/2020 16:32

Strange that it's so quiet here considering what they potentially have, i assume it will not be long before FARN is in the spotlight.

[toffeeman] 04/5/2020 14:32

hash - it's completely different FARN is an injectible SNG is nebulised

(I hold both)

[hashertu] 04/5/2020 13:26

hxxps://www.synairgen.com/covid-19/

Based on my limited understanding of the subject, Synairgen appear to be trying something similar in Southampton university.
Could be competition, but also seems to validate the approach.

[soulected] 02/5/2020 10:28

Faron Pharmaceuticals confident on the potential of both its coronavirus and cancer candidatesIt will also be compared in the study with other treatments, including hydrocortisone medications.These steroid-based interventions, used in patients in respiratory distress, were seen as the potential root cause of a previously failed Faron phase III study of Traumakine.Just weeks after the announcement on REMAP-CAP, Traumakine was also added to the World Health Organisation's Solidarity trial.Faron believes its interferon beta-1a drug may help protect against serious lung complications.It is being administered in combination with the HIV drug lopinavir but, according to Jalkanen, "If it gets to the point where the leak is in the lungs then Traumakine, we believe, is the only drug that can help."The two will be compared with the current standard of care in order to assess efficacy, with early data being available as soon as this month.Faron has donated supplies to treat 2,000 patients, although more people are included in the trial.Licensing partners soughtThe company continues to pursue partnering and licensing discussions for both Traumakine and Clevegen."Clevegen has shown very promising clinical response in MATINS Part I stage, which we believe will transform into significant opportunity when the study moves to the Part II-III expansion stages," Jalkanen said."Traumakine, on the other hand, has a new corticosteroid-free setting through the global REMAP-CAP study, which we believe is one of the most important intensive care studies of the current pandemic environment."Since the beginning of the coronavirus crisis in the UK in mid-March, shares in the biotech have shot up 47% to 367p.

[soulected] 02/5/2020 09:47

httpS://www.google.co.uk/amp/s/www.proactiveinvestors.co.uk/companies/amp/news/918664

[toffeeman] 01/5/2020 09:16

You wait until (if it ever does) hit the top 10 risers - then we will be invaded by numpties - just be grateful until you're not!

[ambyth] 01/5/2020 08:58

I'm in. Its very quiet here

[elliotset] 27/4/2020 07:48

Great news today

[hashertu] 23/4/2020 14:09

Good outcome from the placing.

[dan1nat1] 22/4/2020 21:59

Vaccine development!https://article-directory.org/article/747/53/Faron-Pharmaceuticals-current-progress-on-Covid-19-vaccine"Clevegen, its precision immunotherapy, is a novel anti-Clever-1 antibody with the capability to switch immune suppression to immune activation in different situations, with potential across oncology, infections disease and Covid-19 vaccine development."

[yep1234] 22/4/2020 09:16

FYIhttps://www.faron.com/sites/default/files/Latest%20investor%20presentation_22042020.pdf

[dan1nat1] 21/4/2020 22:15

I think things are moving very quick now we are on remap, the partner situation probably changed the instant we signed up...which wasn't very long ago.Final results maybe 2022, that doesn't mean we won't get updates along the way, and you can bet if Traumakine is as good as we hope that demand for a fast tracked P3 trial will be substantial.

[daffodil4] 21/4/2020 21:37

OK...but would you not have expected Markuu to
have discussed that possibility....Also
REMAP trial results are not expected till 2022
so it would be quicker to go the FDA route??

[dan1nat1] 21/4/2020 20:37

No I am assuming if we are successful in the Remap trial we will quickly move to £15+ and be quite capable of raising funds without the need for a partner.

[daffodil4] 21/4/2020 20:22

dan1nat1

From today's RNS..

" and seeks third party financing for Traumakine to allow
initiation of a US trial following the acceptance by the FDA
of the Company's protocol for a new US Truamakine trial "
So Faron clearly saying that to get FDA approval they need
to complete the trials Inegrity and Calibre...You are
assuming the REMAP trial would be an alternative way,
but Markuu would have confirmed that if it was a possibility
but he did not.......I did wonder if that might be a possibility
you will see if you look back on my earlier posts..but
after reading today's RNS it is clear that Faron are
still looking for a third party to fund the FDA trials..

[soulected] 21/4/2020 19:33

Did you actually read the whole RNS?

[dan1nat1] 21/4/2020 19:07

LOL...don't you realise we might not need a partner now we basically have the trial testing Traumakine being paid for by someone else. If you don't grasp that you really are in the wrong share.

[daffodil4] 21/4/2020 17:10

I disagree......This means that the Partner discussions
they have been saying would hopefully result in a deal
have come to nothing...Very disappointed ..they said
the last placement would see them to Q4 2020 and
we are only just in Q2....These will be flipped
and the price will fall to the placing price...

[davidlloyd] 21/4/2020 16:55

Suggests to me the intel has identified clear insti demand for these then.....
DL